| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/23/1995 | DE4328336A1 Thrombin inhibitor from the saliva of protostomes |
| 02/23/1995 | DE4320677A1 Synthetic peptides for neutralising the infectiosity of the AIDS VIRUS (HIV) |
| 02/23/1995 | CA2590837A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
| 02/23/1995 | CA2169459A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
| 02/23/1995 | CA2169370A1 Antibody-based treatment of hiv infection |
| 02/23/1995 | CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
| 02/23/1995 | CA2169285A1 Class i mhc modulation of surface receptor activity |
| 02/23/1995 | CA2169273A1 Methods of detecting and combating disorders of the central nervous system |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | CA2167942A1 Method of inhibiting kaposi's sarcoma |
| 02/23/1995 | CA2167716A1 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 02/23/1995 | CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides |
| 02/22/1995 | EP0639586A1 Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them |
| 02/22/1995 | EP0639585A1 Elastase inhibitor |
| 02/22/1995 | EP0639226A1 Rna molecule for use in treating leukemias |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 02/22/1995 | EP0535060B1 Antifungal polypeptide, process for producing it |
| 02/22/1995 | EP0506956B1 External preparation for skin |
| 02/22/1995 | EP0478659B1 Interferon purification process |
| 02/22/1995 | EP0438401B1 Combination lock for blood identification system |
| 02/22/1995 | EP0437563B1 Biologically active drug polymer derivatives |
| 02/22/1995 | CN1099040A Linear adhesion inhibitor |
| 02/22/1995 | CN1098942A Treatment of juvenile diabetes |
| 02/21/1995 | US5391714 Polymorphism of human platelet membrane glycoprotein IIIA and diagnostic applications thereof |
| 02/21/1995 | US5391705 Polyfluorinated tripeptide thrombin inhibitors |
| 02/21/1995 | US5391550 Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| 02/21/1995 | US5391497 Human k-casein |
| 02/21/1995 | US5391486 Physiologically active substance BE-16627 |
| 02/21/1995 | US5391485 DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| 02/21/1995 | US5391380 Used in blood coagulation tests; mixed with metal ion chelator |
| 02/21/1995 | CA2130279A1 Elastase inhibitor |
| 02/21/1995 | CA2006144C Microbial process for the production of immunosuppressive antibiotics |
| 02/16/1995 | WO1995004829A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | WO1995004827A1 Tick antigen |
| 02/16/1995 | WO1995004823A1 High molecular weight desulphatohirudin |
| 02/16/1995 | WO1995004821A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | WO1995004820A1 CLONING OF MAMMALIAN INWARD RECTIFIER POTASSIUM CHANNEL cDNAs |
| 02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 02/16/1995 | WO1995004818A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/16/1995 | WO1995004817A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | WO1995004756A1 Complement inhibitor proteins of non-human primates |
| 02/16/1995 | WO1995004755A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/16/1995 | WO1995004753A1 Compositions of fusion proteins containing metallothionein and targeting-protein structural components |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004751A1 Selectin binding glycopeptides |
| 02/16/1995 | WO1995004750A1 Tick derived protease inhibitor |
| 02/16/1995 | WO1995004744A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | WO1995004551A1 Percutaneously absorbable preparation |
| 02/16/1995 | WO1995004549A1 Creating new capillary blood pools for practising bidirectional medicine |
| 02/16/1995 | WO1995004547A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 02/16/1995 | WO1995004544A1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1995004541A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | WO1995004540A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | WO1994029451A3 Humanised antibodies |
| 02/16/1995 | CA2170234A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | CA2169172A1 Percutaneously absorbable preparation |
| 02/16/1995 | CA2168988A1 Polypeptides coded by exon v5 of the cd44 gene as targets for immunotherapy and immunoscintigraphy of tumours |
| 02/16/1995 | CA2168950A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168454A1 Selectin binding glycopeptides |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2167834A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | CA2145767A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/16/1995 | CA2144523A1 High molecular weight desulphatohirudin |
| 02/15/1995 | EP0638645A1 Human TRH receptor, its production and use |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638588A1 Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use |
| 02/15/1995 | EP0638315A1 Antihypoxic agent |
| 02/15/1995 | EP0638314A1 Process for producing plasminogen-containing composition |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638124A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 02/15/1995 | EP0638123A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 02/15/1995 | EP0638104A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
| 02/15/1995 | EP0638091A1 Improved solubilization and stabilization of factor viii complex |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0637964A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy. |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0627900A4 Use of injectable biomaterials for the repair and augmentation of the anal sphincters. |
| 02/15/1995 | EP0573538B1 Peptides for treatment |
| 02/15/1995 | EP0524172B1 A method for isolating factor viii |
| 02/15/1995 | EP0425507B1 Compositions and methods for treating skin conditions and promoting wound healing |
| 02/15/1995 | EP0389570B1 High integrity liposomes and method of preration and use |
| 02/15/1995 | EP0368992B1 Actions of hormones |
| 02/15/1995 | CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives |
| 02/14/1995 | US5389664 Administering benzimidazole compounds to inhibit at pase activity |
| 02/14/1995 | US5389657 Administering as a glutathione stimulator, 2-oxothiazolidine-4-carboxylate; defense to egg/embryo peroxidation |
| 02/14/1995 | US5389647 Renin inhibitors |
| 02/14/1995 | US5389628 Amino and nitro containing tricyclic compounds useful as inhibitors of ace |
| 02/14/1995 | US5389623 Redox carriers for brain-specific drug delivery |
| 02/14/1995 | US5389614 Anticoagulants |
| 02/14/1995 | US5389613 Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis |
| 02/14/1995 | US5389612 Phosphonic peptide inhibitors of bacterial collagenases |
| 02/14/1995 | US5389611 Enzyme inhibitor is obtained by hydrolysis in presence of acid ; heat resistance; bactericides for foods, cosmetics, drugs, feeds |